» Articles » PMID: 26687334

Constructive Remodeling of a Synthetic Endothelial Extracellular Matrix

Overview
Journal Sci Rep
Specialty Science
Date 2015 Dec 22
PMID 26687334
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The construction of well-controllable in vitro models of physiological and pathological vascular endothelium remains a fundamental challenge in tissue engineering and drug development. Here, we present an approach for forming a synthetic endothelial extracellular matrix (ECM) that closely resembles that of the native structure by locally depositing basement membrane materials onto type 1 collagen nanofibers only in a region adjacent to the endothelial cell (EC) monolayer. Culturing the EC monolayer on this synthetic endothelial ECM remarkably enhanced its physiological properties, reducing its vascular permeability, and promoting a stabilized, quiescent phenotype. We demonstrated that the EC monolayer on the synthetic endothelial ECM neither creates non-physiological barriers to cell-cell or cell-ECM interactions, nor hinders molecular diffusion of growth factors and other molecules. The synthetic endothelial ECM and vascular endothelium on it may help us enter in a new phase of research in which various models of the biological barrier behavior can be tested experimentally.

Citing Articles

Microfluidic model for in vitro acute Toxoplasma gondii infection and transendothelial migration.

Kim H, Hong S, Jeong H, Han S, Ahn J, Kim J Sci Rep. 2022; 12(1):11449.

PMID: 35794197 PMC: 9259589. DOI: 10.1038/s41598-022-15305-4.


Engineering a Vascularized Hypoxic Tumor Model for Therapeutic Assessment.

Ando Y, Oh J, Zhao W, Tran M, Shen K Cells. 2021; 10(9).

PMID: 34571851 PMC: 8468635. DOI: 10.3390/cells10092201.


Tissue-engineered vascular microphysiological platform to study immune modulation of xenograft rejection.

Kim T, Yan J, Jang J, Lee G, Lee S, Kim B Sci Adv. 2021; 7(22).

PMID: 34049875 PMC: 8163083. DOI: 10.1126/sciadv.abg2237.


Organ-on-a-chip platforms for evaluation of environmental nanoparticle toxicity.

Lu R, Radisic M Bioact Mater. 2021; 6(9):2801-2819.

PMID: 33665510 PMC: 7900603. DOI: 10.1016/j.bioactmat.2021.01.021.


Remodeling of the Microvasculature: May the Blood Flow Be With You.

Santamaria R, Gonzalez-Alvarez M, Delgado R, Esteban S, Arroyo A Front Physiol. 2020; 11:586852.

PMID: 33178049 PMC: 7593767. DOI: 10.3389/fphys.2020.586852.


References
1.
Cecchelli , DESCAMPS , FENART , Duhem , Lundquist , Rentfel . In vitro model for evaluating drug transport across the blood-brain barrier. Adv Drug Deliv Rev. 2000; 36(2-3):165-178. DOI: 10.1016/s0169-409x(98)00083-0. View

2.
Luscinskas F, Lawler J . Integrins as dynamic regulators of vascular function. FASEB J. 1994; 8(12):929-38. DOI: 10.1096/fasebj.8.12.7522194. View

3.
Martin G, Timpl R . Laminin and other basement membrane components. Annu Rev Cell Biol. 1987; 3:57-85. DOI: 10.1146/annurev.cb.03.110187.000421. View

4.
Sheldon R, Moy A, Lindsley K, Shasby S, Shasby D . Role of myosin light-chain phosphorylation in endothelial cell retraction. Am J Physiol. 1993; 265(6 Pt 1):L606-12. DOI: 10.1152/ajplung.1993.265.6.L606. View

5.
Kido Y, Tamai I, Nakanishi T, Kagami T, Hirosawa I, Sai Y . Evaluation of blood-brain barrier transporters by co-culture of brain capillary endothelial cells with astrocytes. Drug Metab Pharmacokinet. 2004; 17(1):34-41. DOI: 10.2133/dmpk.17.34. View